Quantum eMotion Achieves Key Listing Milestone on NYSE American

Quantum eMotion Corp. graduates from OTCQB to NYSE American exchange, aiming to expand its U.S. investor base and visibility. Shares begin trading under ticker QNC.

Quantum eMotion Corp. is set to graduate from the over-the-counter market, with its shares commencing trading on the NYSE American exchange. This strategic uplisting marks a significant step in the company's engagement with the U.S. capital markets. Existing shareholders are assessing what this transition means for their holdings.

A New Trading Venue Under Ticker QNC

Effective at the market open, the company's common shares will begin trading on the NYSE American under the new ticker symbol QNC. Concurrently, its quotation on the OTCQB Venture Market will be discontinued. This move follows a corporate announcement released on Thursday.

The company's existing listings on the TSX Venture Exchange and the Frankfurt Stock Exchange will remain unchanged. According to the company, no action is required from current shareholders. However, investors who purchased shares through the OTCQB are advised to verify their brokerage statements to ensure their positions correctly reflect the new listing.

Strategic Rationale and Regulatory Preparation

Quantum eMotion's path to this uplisting was paved earlier this year. In January, the company filed a Form 40-F registration with U.S. regulators, establishing the necessary foundation for the exchange transfer.

Management cites broader strategic goals for the move: expanding its shareholder base and enhancing its visibility within the United States. The NYSE American exchange is recognized as a platform for small to mid-cap companies and can structurally attract greater attention from institutional investors.

Market Anticipation and Recent Developments

The approval for the NYSE American listing generated noticeable trading activity on the TSX Venture Exchange last week, with heightened volume reported in the preceding period. Data from Yahoo Finance indicated the company's market capitalization stood at approximately 1.12 billion CAD as of late January.

In the months leading up to this transition, Quantum eMotion announced several operational milestones. A December report highlighted that the stock had become the largest holding within the Defiance Quantum ETF. Furthermore, the company concluded December by announcing security testing for its Quantum Random Number Generator (QRNG) technology in fields including DeFi and post-quantum simulations.

Additional partnerships were disclosed, encompassing a remote patient monitoring project announced by Greybox and a joint development committee with Energy Plug Technologies Inc. for QRNG chip integration. Prototype field tests for these initiatives are scheduled for the first quarter of 2026.

The inaugural trading session on the NYSE American will serve as a practical test, revealing the smoothness of the technical transition and whether improved access for U.S. investors translates into tangible market activity.